Implications of the RADAR trial: the dignity of risk taking

Affiliations

¹ Copenhagen Research Center for Mental Health, Mental Health Center Copenhagen, Copenhagen University Hospital, Hellerup 2900, Denmark. Electronic address: helene.speyer@regionh.dk.
² Department of Community Mental Health, University of Haifa, Haifa, Israel.

Comment

Helene Speyer et al. Lancet Psychiatry. 2024 Jan.

. 2024 Jan;11(1):10.

doi: 10.1016/S2215-0366(23)00368-1.

¹ Copenhagen Research Center for Mental Health, Mental Health Center Copenhagen, Copenhagen University Hospital, Hellerup 2900, Denmark. Electronic address: helene.speyer@regionh.dk.
² Department of Community Mental Health, University of Haifa, Haifa, Israel.

No abstract available

Conflict of interest statement

We declare no competing interests.

Antipsychotic dose reduction and discontinuation versus maintenance treatment in people with schizophrenia and other recurrent psychotic disorders in England (the RADAR trial): an open, parallel-group, randomised controlled trial.
Moncrieff J, Crellin N, Stansfeld J, Cooper R, Marston L, Freemantle N, Lewis G, Hunter R, Johnson S, Barnes T, Morant N, Pinfold V, Smith R, Kent L, Darton K, Long M, Horowitz M, Horne R, Vickerstaff V, Jha M, Priebe S. Moncrieff J, et al. Lancet Psychiatry. 2023 Nov;10(11):848-859. doi: 10.1016/S2215-0366(23)00258-4. Epub 2023 Sep 28. Lancet Psychiatry. 2023. PMID: 37778356 Clinical Trial.